TGF-β signalling from cell membrane to nucleus through SMAD proteins

Nature

Volumn 390, Issue 6659, 1997, Pages 465-471

  Heldin, Carl Henrik ^a   Miyazono, Kohei ^b   Ten Dijke, Peter ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA;

CELL MEMBRANE; CELL NUCLEUS; OLIGOMERIZATION; PHOSPHORYLATION; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL MEMBRANE; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031438047     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/37284     Document Type: Review

References (101)

1. Massagué, J., Hata, A. & Liu, F. TGF-β signalling through the Smad pathway. Trends Cell Biol. 7, 187-192 (1997).
2. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. & Massagué, J. Mechanism of activation of the TGF-β receptor. Nature 370, 341-347 (1994).
3. Henis, Y. I., Moustakas, A., Lin, H. Y. & Lodish, H. F. The types II and III transforming growth factor-β receptors form homo-oligomers. J. Cell Biol. 126, 139-154 (1994).
4. Chen, R.-H. & Derynck, R. Homomeric interactions between type II transforming growth factor-β receptors. J. Biol. Chem. 269, 22868-22874 (1994).
5. Lu, K. X. & Lodish, H. F. Signalling by chimeric erythropoietin-TGF-β receptors: Homodimerization of the cytoplasmic domain of the type I TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. EMBO J. 15, 4485-4496 (1996).
6. Feng, X.-H. & Derynck, R. Ligand-independent activation of transforming growth factor (TGF) β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors. J. Biol. Chem. 271, 13123-13129 (1996).
7. Wieser, R., Wrana, J. L. & Massagué, J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208 (1995).
8. Attisano, L., Wrana, J. L., Montalvo, E. & Massagué, J. Activation of signalling by the activin receptor complex. Mol. Cell. Biol. 16, 1066-1073 (1996).
9. Willis, S. A., Zimmerman, C. M., Li, L. & Mathews, L. S. Formation and activation by phosphorylation of activin receptor complexes. Mol. Endocrinol. 10, 367-379 (1996).
10. Rodriguez, C., Chen, F., Weinberg, R. A. & Lodish, H. F. Cooperative binding of transforming growth factor (TGF)-β2 to the types I and II TGF-β receptors. J. Biol. Chem. 270, 15919-15922 (1995).
11. Liu, F., Ventura, F., Doody, J. & Massagué, J. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol..15, 3479-3486 (1995).
12. Nohno, T. et al. Identification of a human type Ii receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J. Biol. Chem. 270, 22522-22526 (1995).
13. Rosenzweig, B. L. et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl Acad. Sci. USA 92, 7632-7636 (1995).
14. Yamashita, H., ten Dijke, P., Franzén, P., Miyazono, K. & Heldin, C.-H. Formation of heterooligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem. 269, 20172-20178 (1994).
15. Weis-Garcia, F. & Massagué, J. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15, 276-289 (1996).
16. Cárcamo, J. et al. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol. Cell. Biol. 14, 3810-3821 (1994).
17. Feng, X.-H. & Derynck, R. A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J. 16, 3912-3923 (1997).
18. McCaffrey, T. A. et al. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-β1. J. Clin. Invest. 96, 2667-2675 (1995).
19. Sankar, S. et al. Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest. 97, 1436-1446 (1996).
20. Chen, R. H., Ebner, R. & Derynck, R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260, 1335-1338 (1993).
21. Souchelnytskyi, S., ten Dijke, P., Miyazono, K. & Heldin, C.-H. Phosphorylation of Ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses. EMBO J. 15, 6231-6240 (1996).
22. Luo, K. X. & Lodish, H. F. Positive and negative regulation of type II TGFβ receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J. 16, 1970-1981 (1997).
23. Lawler, S. et al. The type II transforming growth factor-β receptor autophosphoryltes not only on serine and threonine but also on tyrosine residues. J. Biol. Chem. 272, 14850-14859 (1997).
24. Nakamura, T. et al. Isolation and characterization of activin receptor from mouse embryonal carcinoma cells: Identification of its serine/threonine/tyrosine protein kinase activity. J. Biol. Chem. 267, 18924-18928 (1992).
25. Raftery, L. A., Twombly, V., Wharton, K. & Gelbart, W. M. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics 139, 241-254 (1995).
26. Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H. & Gelbart, W. M. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139, 1347-1358 (1995).
27. Wiersdorff, V., Lecuit, T., Cohen, S. M. & Mlodzik, M. Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye. Development 122, 2153-2162 (1996).
28. Newfeld, S. J., Chartoff, E. H., Graff, J. M., Melton, D. A. & Gelbart, W. M. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-β responsiveness cells. Development 122, 2099-2108 (1996).
29. Hoodless, P. A. et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489-500 (1996).
30. Newfeld, S. J. et al. Mothers against dpp participates in a DPP/TGF-β responsive serine-threonine kinase signal transduction cascade. Development 124, 3167-3176 (1997).
31. Savage, C. et al. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor β pathway components. Proc. Natl Acad. Sci. USA 93, 790-794 (1996).
32. Graff, J. M., Bansal, A. & Melton, D. A. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85, 479-487 (1996).
33. Thomsen, G. H. Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. Development 122, 2359-2366 (1996).
34. Liu, F. et al. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623 (1996).
35. Baker, J. C. & Harland, R. M. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10, 1880-1889 (1996).
36. Eppert, K. et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552 (1996).
37. Zhang, Y., Feng, X.-H., Wu, R.-Y. & Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383, 168-172 (1996).
38. Nakao, A. et al. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362 (1997).
39. Chen, Y., Lebrun, J. J. & Vale, W. Regulation of transforming growth factor β-and activin-induced transcription by mammalian Mad proteins. Proc. Natl Acad. Sci. USA 93, 12992-12997 (1996).
40. Kretzschmar, M., Liu, F., Hata, A., Doody, J. & Massagué, J. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11, 984-995 (1997).
41. Suzuki, A., Chang, C., Yingling, J. M., Wang, X.-F. & Hemmati-Brivanlous, A. Smad5 induces ventral fates in Xenopus embryo. Dev. Biol. 184, 402-405 (1997).
42. Watanabe, T. K. et al. Cloning and characterization of a novel member of the human Mad gene family. Genomics 42, 446-451 (1997).
43. Lechleider, R. J., de Caestecker, M. P., Dehejia, A., Polymeropoulos, M. H. & Roberts, A. B. Serine phosphorylation, chroosomal localization, and transforming growth factor-β signal transduction by human bsp-1. J. Biol. Chem. 271, 17617-17620 (1996).
44. Yingling, J. M. et al. Mammalian dwarfins are phosphorylated in response to transforming growth factor β and are implicated in control of cell growth. Proc. Natl Acad. Sci. USA 93, 8940-8944 (1996).
45. Marcías-Silva, M. et al. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224 (1996).
46. Souchelnytskyi, S. et al. Phosphorylation of Ser465 and Ser467 in the C-terminus of Smad2 mediates interaction with Smad4 and is required for TGF-β signalling. J. Biol. Chem. 272, 28107-28115 (1997).
47. Abdollah, S. et al. TβRI phosphorylation of Smad2 on Ser465 and 467 is required for Smad2/Smad4 complex formation and signalling. J. Biol. Chem. 272, 27678-27685 (1997).
48. Lagna, G., Hata, A., Hammati-Brivanlou, A. & Massagué, J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383, 832-836 (1996).
49. Wu, R.-Y., Zhang, Y., Feng, X.-Y. & Derynck, R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol. Cell. Biol. 17, 2521-2528 (1997).
50. Zhang, Y., Musci, T. & Derynck, R. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr. Biol. 7, 270-276 (1997).
51. Padgett, R. W., Savage, C. & Das, P. Genetic and biochemical analysis of TGFβ signal transduction. Cytokine Growth Factor Rev. 8, 1-9 (1997).
52. de Caestecker, M. P. et al. Characterization of functional domains within smad4/DPC4. J. Biol. Chem. 272, 13690-13696 (1997).
53. Meersseman, G. et al. The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation. Mech. Dev. 61, 127-140 (1997).
54. Hata, A., Lo, R. S., Wotton, D., Lagna, G. & Massagué, J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388, 82-87 (1997).
55. Schutte, M. et al. DPC4 gene in various tumour types. Cancer Res. 56, 2527-2530 (1996).
56. Kim, J., Johnson, K., Chen, H. J., Carroll, S. & Laughon, A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388, 304-308 (1997).
57. Shi, Y., Hata, A., Lo, R. S., Massagué, J. & Pavletich, N. P. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388, 87-93 (1997).
58. Imamura, T. et al. Smad6 is an inhibitor in the TGF-β superfamily signalling. Nature 389, 622-626 (1997).
59. Nakao, A. et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389, 631-635 (1997).
60. Hayashi, H. et al. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89, 1165-1173 (1997).
61. Topper, J. N. et al. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl Acad. Sci. USA 94, 9314-9319 (1997).
62. Tsuneizumi, K. et al. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature 389, 627-631 (1997).
63. Watabe, T. et al. Molecular mechanisms of Spemann's organizer formation: conserved growth factor synergy between Xenopus and mouse. Genes Dev. 9, 3038-3050 (1995).
64. Kaufmann, E. et al. Antagonistic actions of activin A and BMP-2/4 control dorsal lip-specific activation of the early response gene XFD-1' in Xenopus laevis embryos. EMBO J. 15, 6739-6749 (1996).
65. Ladher, R., Mohun, T. J., Smith, J. C. & Snape, A. M. Xom: a Xenopus homeobox gene that mediates the early effects of BMP-4. Development 122, 2385-2394 (1996).
66. Gawantka, V., Delius, H., Hirschfeld, K., Blumenstock, C. & Niehrs, C. Antagonizing the Spemann organizer: role of the homeobox gene Xvent-1. EMBO J. 14, 6268-6279 (1995).
67. Suzuki, A., Ueno, N. & Hemmati-Brivanlou, A. Xenopus msx1 mediates epidermal induction and neural inhibition by BMP4. Development 124, 3037-3044 (1997).
68. Keeton, M. R., Curriden, S. A., van Zonneveld, A. J. & Loskutoff, D. J. Identification of regulatory sequences in the type I plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem. 266, 23048-23052 (1991).
69. Kim, S. J. et al. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10, 1492-1497 (1990).
70. Datto, M. B., Yu, Y. & Wang, X.-F. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270, 28623-28628 (1995).
71. INK4B through an Sp1 consensus site. J. Biol. Chem. 270, 26750-26753 (1995).
72. Chen, X., Rubock, M. J. & Whitman, M. A transcriptional partner for MAD proteins in TGF-β signalling. Nature 383, 691-696 (1996).
73. Chen, X. et al. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89 (1997).
74. Arora, K. et al. The Drosophila schnurri gene acts in the Dpp/TGF-β signaling pathway and encodes a transcription factor homologous to the human MBP family. Cell 81, 781-790 (1995).
75. Grieder, N. C., Nellen, D., Burke, R., Basler, K. & Affolter, M. schnurri is required for Drosophila Dpp signaling and encodes a zinc finger protein similar to the mammalian transcription factor PRDII-BF1. Cell 81, 791-800 (1995).
76. Wilson, P. A., Lagna, G., Suzuki, A. & Hemmati-Brivanlou, A. Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1. Development 124, 3177-3184 (1997).
77. Charng, M.-J., Kinnunen, P., Hawker, J., Brand, T. & Schneider, M. D. FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-β receptors. J. Biol. Chem. 271, 22941-22944 (1996).
78. Wang, T. et al. The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell 86, 435-444 (1996).
79. Chen, Y. G., Liu, F. & Massagué, J. Mechanism of TGFβ receptor inhibition by FKBP12. EMBO J. 16, 3866-3876 (1997).
80. Kawabata, M., Imamura, T., Miyazono, K., Engel, M. E. & Moses, H. L. Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α. J. Biol. Chem. 270, 29628-29631 (1995).
81. Ventura, F., Liu, F., Doody, J. & Massagué, J. Interaction of transforming growth factor-β receptor I with farnesyl-protein transferase-α in yeast and mammalian cells. J. Biol. Chem. 271, 13931-13934 (1996).
82. Ras farnesyltransferase α subunit in TGF-β and activin signaling. Science 271, 1120-1122 (1996).
83. Reddy, K. B., Karode, M. C., Harmony, J. A. K. & Howe, P. H. Interaction of transforming growth factor β receptors with apolipoprotein J/clusterin. Biochemistry 35, 309-314 (1996).
84. Chen, R.-H., Miettinen, P. J., Maruoka, E. M., Choy, L. & Derynck, R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377, 548-552 (1995).
85. Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011 (1995).
86. Hartsough, M. T. et al. Altered transforming growth factor β signaling in epithelial cells when Ras activation is blocked. J. Biol. Chem. 271, 22368-22375 (1996).
87. Mucsi, I., Skorecki, K. L. & Goldberg, H. J. Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-β1 on gene expression. J. Biol. Chem. 271, 16567-16572 (1996).
88. Atfi, A., Djelloul, S., Chastre, E., Davis, R. R. & Gespach, C. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J. Biol. Chem. 272, 1429-1432 (1997).
89. Frey, R. S. & Mulder, K. M. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase Jun N-terminal kinase activation by transforming growth factor β in the negative growth control of breast cancer cells. Cancer Res. 57, 628-633 (1997).
90. Cui, W. et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531-542 (1996).
91. Markowitz, S. D. & Roberts, A. B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine & Growth Factor Rev. 7, 93-102 (1996).
92. Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338 (1995).
93. Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353 (1996).
94. Riggins, G. J. et al. Mad-related genes in the human. Nature Genet. 13, 347-349 (1996).
95. Riggins, R. G., Kinzler, K. W., Vogelstein, B. & Thiagalingam, S. Frequency of Smad gene mutations in human cancers. Cancer Res. 57, 2578-2580 (1997).
96. Hannon, G. J. & Beach, D. p15INK4B is a potential effector of TGF-β-induced cell-cycle arrest. Nature 371, 257-261 (1994).
97. Iavarone, A. & Massagué. J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387, 417-422 (1997).
98. Galaktionov, K., Chen, X. & Beach, D. Cdc25 cell-cycle phosphatase as a target of c-Myc. Nature 382, 511-517 (1996).
99. Pietenpol, J. A. et al. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61, 777-785 (1990).
100. Ihle, J. N. STATs: Signal transducers and activators of transcription. Cell 84, 331-334 (1996).
101. Krerzschmar, M., Doody, J. & Massagué, J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389, 618-622 (1997).